{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T05:40:29Z","timestamp":1698644429188},"reference-count":26,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2001,12,25]],"date-time":"2001-12-25T00:00:00Z","timestamp":1009238400000},"content-version":"vor","delay-in-days":380,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatrics International"],"published-print":{"date-parts":[[2000,12,10]]},"abstract":"<jats:p> <jats:bold>Abstract<\/jats:bold>\n          <jats:bold>\n            <jats:italic>Background<\/jats:italic>\n          <\/jats:bold>: The aim of the present study was to evaluate the efficacy of treatment with recombinant interferon (IFN)\u2010\u03b12b in 12 children with chronic hepatitis B who had previously undergone therapy for cancer.<\/jats:p><jats:p> <jats:bold>\n            <jats:italic>Methods<\/jats:italic>\n          <\/jats:bold>: Nine children had acute leukemias and the other three children had solid tumors. The mean (\u00b1SD) age of the children was 8.4~3.8 years (range 4\u201316 years). All cases were hepatitis B virus (HBV)\u2010DNA positive and 11 were hepatitis B e antigen (HBeAg) positive. One was anti\u2010HBe positive (mutant strain). Four cases were anti\u2010delta IgG positive. Liver biopsy revealed chronic hepatitis B in 11 patients and cirrhosis in one patient. Interferon\u2010\u03b12b was given at a dose of 5 MU\/m\n\t\t\t\t\t<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"#b2\"><jats:sup>2<\/jats:sup><\/jats:ext-link> three times a week, subcutaneously, for 12 months.<\/jats:p><jats:p> <jats:bold>\n            <jats:italic>Results<\/jats:italic>\n          <\/jats:bold>: Elimination of serum HBV\u2010DNA was obtained in three cases, but a further three patients demonstrated a marked decrease in HBV\u2010DNA levels after therapy. Three of 11 patients seroconverted from HBeAg to anti\u2010HBe. Alanine aminotransferase (ALT) levels returned to normal in three of nine cases in whom the ALT levels were high before treatment. At the end of therapy, the mean histologic activity index score was significantly diminished (<jats:italic>P<\/jats:italic>=0.0039).<\/jats:p><jats:p> <jats:bold>\n            <jats:italic>Conclusions<\/jats:italic>\n          <\/jats:bold>: In conclusion, a 12 month course of IFN\u2010\u03b12b induces some beneficial effects on virologic, biochemical and histologic indices in children with chronic hepatitis B who have previously undergone therapy for cancer.<\/jats:p>","DOI":"10.1046\/j.1442-200x.2000.01312.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T16:50:01Z","timestamp":1047487801000},"page":"642-646","source":"Crossref","is-referenced-by-count":3,"title":["Efficacy of interferon\u2010\u03b12b treatment in children with chronic hepatitis B who have previously undergone therapy for cancer"],"prefix":"10.1111","volume":"42","author":[{"given":"Erhun","family":"Kasirga","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sitki","family":"Isenlik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serap","family":"Aksoylar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I\u015fin","family":"Yaprak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sava\u015f","family":"Kansoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00fcl","family":"Y\u00fcce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2001,12,25]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1007420725704"},{"key":"e_1_2_5_3_2","first-page":"78","article-title":"A prospective study on incidence of hepatitis B and C infections amongst patients with lymphoproliferative disorders.","volume":"107","author":"Dutta U","year":"1998","journal-title":"Indian J. Med. Res."},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.1890370202"},{"key":"e_1_2_5_5_2","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0016-5085(75)80054-0","article-title":"Serial studies of hepatitis\u2010associated antigen and antibody in patients receiving antitumor chemotherapy for myeloproliferative and lymphoproliferative disorders.","volume":"68","author":"Wands JR","year":"1975","journal-title":"Gastroenterology"},{"key":"e_1_2_5_6_2","unstructured":"BalistreriWF.Acute and chronic viral hepatitis. In: Suchy FJ (ed.).Liver Disease in Children 1st edn. Mosby\u2010Year Book Inc. St Louis MO 1994; 460\u2013509."},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002770050440"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0304-3835(97)00535-1"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1093\/tropej\/42.5.262"},{"key":"e_1_2_5_10_2","first-page":"142","article-title":"Interferon alpha in treatment of chronic hepatitis B in children with leukemias and lymphomas.","volume":"90","author":"Rokicka\u2010Milewska R","year":"1993","journal-title":"Pol. Arch. Med. Wewn."},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840010511"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840130605"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(98)70318-X"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510290312"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-199709000-00009"},{"key":"e_1_2_5_16_2","first-page":"42","article-title":"The Delta agent.","volume":"7","author":"Rizzetto M.","year":"1983","journal-title":"Hepatology"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.1991.tb01162.x"},{"key":"e_1_2_5_18_2","first-page":"141","article-title":"Alpha interferon in the treatment of chronic delta hepatitis.","volume":"21","author":"Rosina F","year":"1989","journal-title":"Ital. J. Gastroenterol."},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2008-1043904"},{"key":"e_1_2_5_20_2","first-page":"103","article-title":"Hepatitis B virus infection in children receiving multidrug cancer chemotherapy.","volume":"8","author":"Repp R","year":"1993","journal-title":"Arch. Virol. Suppl."},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1159\/000200221"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/98.4.402"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510290230"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(93)90281-G"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/0049-0172(89)90085-1"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780311201"},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780330717"}],"container-title":["Pediatrics International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1442-200x.2000.01312.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1442-200x.2000.01312.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T17:50:25Z","timestamp":1698601825000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1442-200x.2000.01312.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,12,10]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2000,12,10]]}},"alternative-id":["10.1046\/j.1442-200x.2000.01312.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1442-200x.2000.01312.x","archive":["Portico"],"relation":{},"ISSN":["1328-8067","1442-200X"],"issn-type":[{"value":"1328-8067","type":"print"},{"value":"1442-200X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,12,10]]}}}